82 I.M. Carvalho et al. / Journal of Controlled Release 202 (2015) 76–82
[68] K. Bilgihan, U. Adiguzel, C. Sezer, G. Akyol, B. Hasanreisoglu, Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy, Ophthalmologica 215 (3) (2001) 192–196. http://dx.doi.org/10.1159/000050857.
[69] T. Yilmaz, O. Aydemir, I.H. Ozercan, B. Ustundağ, Effects of vitamin e, pentoxifylline and aprotinin on light-induced retinal injury, Ophthalmologica 221 (3) (2007) 159–166. http://dx.doi.org/10.1159/000099295.
[70] A. Tieppo, C.J. White, A.C. Paine, M.L. Voyles, M.K. McBride, M.E. Byrne, Sustained in vivo release from imprinted therapeutic contact lenses, J. Control. Release 157 (3) (2012) 391–397. http://dx.doi.org/10.1016/j.jconrel.2011.09.087.
[71] B. Malaekeh-Nikouei, F.A. Ghaeni, V.S. Motamedshariaty, S.A. Mohajeri, Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses, J. Appl. Polym. Sci. 126 (1) (2012) 387–394. http://dx.doi.org/10.1002/app.36625.
[72] H. Hiratani, Y. Mizutani, C. Alvarez-Lorenzo, Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities, Macromol. Biosci. 5 (8) (2005) 728–733. http://dx.doi.org/10.1002/****.200500065.
[73] S. Venkatesh, J. Saha, S. Pass, M.E. Byrne, Transport and structural analysis of molec- ular imprinted hydrogels for controlled drug delivery, Eur. J. Pharm. Biopharm. 69 (3) (2008) 852–860. http://dx.doi.org/10.1016/j.ejpb.2008.01.036.
[74] M.E. Byrne, V. Salian, Molecular imprinting within hydrogels II: progress and analy- sis of the field, Int. J. Pharm. 364 (2) (2008) 188–212. http://dx.doi.org/10.1016/j. ijpharm.2008.09.002.
[75] C.J. White, A. Tieppo, M.E. Byrne, Controlled drug release from contact lenses: a com- prehensive review from 1965–present, J. Drug Deliv. Sci. Technol. 21 (5) (2011) 369–384. http://dx.doi.org/10.1016/S1773-2247(11)50062-0.
[76] C. Alvarez-Lorenzo, F. Yañez, R. Barreiro-Iglesias, A. Concheiro, Imprinted soft con- tact lenses as norfloxacin delivery systems, J. Control. Release 113 (3) (2006) 236–244. http://dx.doi.org/10.1016/j.jconrel.2006.05.003.
[77] A.D. Vaughan, J.B. Zhang, M.E. Byrne, Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization, AICHE J. 56 (1) (2010) 268–279. http://dx.doi.org/10.1002/aic.11949.
[78] M. Ali, M.E. Byrne, Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses, Pharm. Res. 26 (3) (2009) 714–726. http://dx.doi.org/10.1007/s11095-008-9818-6.
[79] C.J. White, M.K. McBride, K.M. Pate, A. Tieppo, M.E. Byrne, Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, ex- tended wear silicone hydrogel contact lenses, Biomaterials 32 (24) (2011) 5698–5705. http://dx.doi.org/10.1016/j.biomaterials.2011.04.044.
[80] J. Xu, X. Li, F. Sun, In vitro and in vivo evaluation of ketotifen fumarate-loaded sili- cone hydrogel contact lenses for ocular drug delivery, Drug Deliv. 18 (2) (2011) 150–158. http://dx.doi.org/10.3109/10717544.2010.522612.
[81] C. Alvarez-Lorenzo, H. Hiratani, J.L. Gómez-Amoza, R. Martínez-Pacheco, C. Souto, A. Concheiro, Soft contact lenses capable of sustained delivery of timolol, J. Pharm. Sci. 91 (10) (2002) 2182–2192. http://dx.doi.org/10.1002/jps.10209.
[82] H. Hiratani, A. Fujiwara, Y. Tamiya, Y. Mizutani, C. Alvarez-Lorenzo, Ocular release of timolol from molecularly imprinted soft contact lenses, Biomaterials 26 (11) (2005) 1293–1298. http://dx.doi.org/10.1016/j.biomaterials.2004.04.030.
[83] B. Malaekeh-Nikouei, S.A. Vahabzadeh, S.A. Mohajeri, Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide, Curr. Drug Deliv. 10 (3) (2013) 279–285 (Available at: http://www.ncbi.nlm.nih. gov/pubmed/23360228. Accessed June 18, 2014).
[84] D. Gulsen, A. Chauhan, Ophthalmic drug delivery through contact lenses, Invest. Ophthalmol. Vis. Sci. 45 (7) (2004) 2342–2347 (Available at: http://www.ncbi. nlm.nih.gov/pubmed/15223815. Accessed June 18, 2014).
[85] D. Gulsen, A. Chauhan, Dispersion of microemulsion drops in HEMA hydrogel: a po- tential ophthalmic drug delivery vehicle, Int. J. Pharm. 292 (1–2) (2005) 95–117. http://dx.doi.org/10.1016/j.ijpharm.2004.11.033.
[86] C.-C. Li, M. Abrahamson, Y. Kapoor, A. Chauhan, Timolol transport from microemulsions trapped in HEMA gels, J. Colloid Interface Sci. 315 (1) (2007) 297–306. http://dx.doi.org/10.1016/j.jcis.2007.06.054.
[87] Y. Kapoor, A. Chauhan, Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels, Int. J. Pharm. 361 (1–2) (2008) 222–229. http://dx.doi.org/10.1016/j.ijpharm.2008.05.028.
[88] H.D. Perry, E.D. Donnenfeld, A.J. Kanellopoulos, G.A. Grossman, Topical cyclosporin A in the management of postkeratoplasty glaucoma, Cornea 16 (3) (1997) 284–288 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9143799. Accessed June 18, 2014).
[89] Y. Kapoor, J.C. Thomas, G. Tan, V.T. John, A. Chauhan, Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs, Biomaterials 30 (5) (2009) 867–878. http://dx.doi.org/10.1016/j.biomaterials.2008.10.032.
[90] A. Danion, H. Brochu, Y. Martin, P. Vermette, Fabrication and characterization of con- tact lenses bearing surface-immobilized layers of intact liposomes, J. Biomed. Mater. Res. A 82 (1) (2007) 41–51. http://dx.doi.org/10.1002/jbm.a.31147.
[91] A. Danion, I. Arsenault, P. Vermette, Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin, J. Pharm. Sci. 96 (9) (2007) 2350–2363. http://dx.doi.org/10.1002/jps.20871.
[92] H.J. Jung, A. Chauhan, Ophthalmic drug release by contact lenses, 7(3)2012. 1–3. [93] H.J. Jung, M. Abou-Jaoude, B.E. Carbia, C. Plummer, A. Chauhan, Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone–hydrogel contact lenses, J. Control. Release 165 (1) (2013) 82–89. http://dx.doi.org/10.1016/j.
jconrel.2012.10.010.
[94] J.B. Ciolino, C.F. Stefanescu, A.E. Ross, et al., In vivo performance of a drug-eluting
contact lens to treat glaucoma for a month, Biomaterials 35 (1) (2014) 432–439.
http://dx.doi.org/10.1016/j.biomaterials.2013.09.032.
[95] T. Loftsson, M. Másson, M.E. Brewster, Self-association of cyclodextrins and cyclo-
dextrin complexes, J. Pharm. Sci. 93 (5) (2004) 1091–1099. http://dx.doi.org/
10.1002/jps.20047.
[96] J.-F.R. Dos Santos, R. Couceiro, A. Concheiro, J.-J. Torres-Labandeira, C. Alvarez-
Lorenzo, Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/re- lease properties, Acta Biomater. 4 (3) (2008) 745–755. http://dx.doi.org/10.1016/j. actbio.2007.12.008.
[97] J. Xu, X. Li, F. Sun, Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release, Acta Biomater. 6 (2) (2010) 486–493. http://dx. doi.org/10.1016/j.actbio.2009.07.021.
[98] R.X. Kang, The intraocular pressure depressive effect of puerarin, Zhonghua Yan Ke Za Zhi 29 (6) (1993) 336–339 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 7912669. Accessed June 18, 2014).
[99] M.J. García-Fernández, N. Tabary, B. Martel, et al., Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses, Carbohydr. Polym. 98 (2) (2013) 1343–1352. http://dx.doi.org/10.1016/j.carbpol.2013.08.003.
[68] K. Bilgihan, U. Adiguzel, C. Sezer, G. Akyol, B. Hasanreisoglu, Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy, Ophthalmologica 215 (3) (2001) 192–196. http://dx.doi.org/10.1159/000050857.
[69] T. Yilmaz, O. Aydemir, I.H. Ozercan, B. Ustundağ, Effects of vitamin e, pentoxifylline and aprotinin on light-induced retinal injury, Ophthalmologica 221 (3) (2007) 159–166. http://dx.doi.org/10.1159/000099295.
[70] A. Tieppo, C.J. White, A.C. Paine, M.L. Voyles, M.K. McBride, M.E. Byrne, Sustained in vivo release from imprinted therapeutic contact lenses, J. Control. Release 157 (3) (2012) 391–397. http://dx.doi.org/10.1016/j.jconrel.2011.09.087.
[71] B. Malaekeh-Nikouei, F.A. Ghaeni, V.S. Motamedshariaty, S.A. Mohajeri, Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses, J. Appl. Polym. Sci. 126 (1) (2012) 387–394. http://dx.doi.org/10.1002/app.36625.
[72] H. Hiratani, Y. Mizutani, C. Alvarez-Lorenzo, Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities, Macromol. Biosci. 5 (8) (2005) 728–733. http://dx.doi.org/10.1002/****.200500065.
[73] S. Venkatesh, J. Saha, S. Pass, M.E. Byrne, Transport and structural analysis of molec- ular imprinted hydrogels for controlled drug delivery, Eur. J. Pharm. Biopharm. 69 (3) (2008) 852–860. http://dx.doi.org/10.1016/j.ejpb.2008.01.036.
[74] M.E. Byrne, V. Salian, Molecular imprinting within hydrogels II: progress and analy- sis of the field, Int. J. Pharm. 364 (2) (2008) 188–212. http://dx.doi.org/10.1016/j. ijpharm.2008.09.002.
[75] C.J. White, A. Tieppo, M.E. Byrne, Controlled drug release from contact lenses: a com- prehensive review from 1965–present, J. Drug Deliv. Sci. Technol. 21 (5) (2011) 369–384. http://dx.doi.org/10.1016/S1773-2247(11)50062-0.
[76] C. Alvarez-Lorenzo, F. Yañez, R. Barreiro-Iglesias, A. Concheiro, Imprinted soft con- tact lenses as norfloxacin delivery systems, J. Control. Release 113 (3) (2006) 236–244. http://dx.doi.org/10.1016/j.jconrel.2006.05.003.
[77] A.D. Vaughan, J.B. Zhang, M.E. Byrne, Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization, AICHE J. 56 (1) (2010) 268–279. http://dx.doi.org/10.1002/aic.11949.
[78] M. Ali, M.E. Byrne, Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses, Pharm. Res. 26 (3) (2009) 714–726. http://dx.doi.org/10.1007/s11095-008-9818-6.
[79] C.J. White, M.K. McBride, K.M. Pate, A. Tieppo, M.E. Byrne, Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, ex- tended wear silicone hydrogel contact lenses, Biomaterials 32 (24) (2011) 5698–5705. http://dx.doi.org/10.1016/j.biomaterials.2011.04.044.
[80] J. Xu, X. Li, F. Sun, In vitro and in vivo evaluation of ketotifen fumarate-loaded sili- cone hydrogel contact lenses for ocular drug delivery, Drug Deliv. 18 (2) (2011) 150–158. http://dx.doi.org/10.3109/10717544.2010.522612.
[81] C. Alvarez-Lorenzo, H. Hiratani, J.L. Gómez-Amoza, R. Martínez-Pacheco, C. Souto, A. Concheiro, Soft contact lenses capable of sustained delivery of timolol, J. Pharm. Sci. 91 (10) (2002) 2182–2192. http://dx.doi.org/10.1002/jps.10209.
[82] H. Hiratani, A. Fujiwara, Y. Tamiya, Y. Mizutani, C. Alvarez-Lorenzo, Ocular release of timolol from molecularly imprinted soft contact lenses, Biomaterials 26 (11) (2005) 1293–1298. http://dx.doi.org/10.1016/j.biomaterials.2004.04.030.
[83] B. Malaekeh-Nikouei, S.A. Vahabzadeh, S.A. Mohajeri, Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide, Curr. Drug Deliv. 10 (3) (2013) 279–285 (Available at: http://www.ncbi.nlm.nih. gov/pubmed/23360228. Accessed June 18, 2014).
[84] D. Gulsen, A. Chauhan, Ophthalmic drug delivery through contact lenses, Invest. Ophthalmol. Vis. Sci. 45 (7) (2004) 2342–2347 (Available at: http://www.ncbi. nlm.nih.gov/pubmed/15223815. Accessed June 18, 2014).
[85] D. Gulsen, A. Chauhan, Dispersion of microemulsion drops in HEMA hydrogel: a po- tential ophthalmic drug delivery vehicle, Int. J. Pharm. 292 (1–2) (2005) 95–117. http://dx.doi.org/10.1016/j.ijpharm.2004.11.033.
[86] C.-C. Li, M. Abrahamson, Y. Kapoor, A. Chauhan, Timolol transport from microemulsions trapped in HEMA gels, J. Colloid Interface Sci. 315 (1) (2007) 297–306. http://dx.doi.org/10.1016/j.jcis.2007.06.054.
[87] Y. Kapoor, A. Chauhan, Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels, Int. J. Pharm. 361 (1–2) (2008) 222–229. http://dx.doi.org/10.1016/j.ijpharm.2008.05.028.
[88] H.D. Perry, E.D. Donnenfeld, A.J. Kanellopoulos, G.A. Grossman, Topical cyclosporin A in the management of postkeratoplasty glaucoma, Cornea 16 (3) (1997) 284–288 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9143799. Accessed June 18, 2014).
[89] Y. Kapoor, J.C. Thomas, G. Tan, V.T. John, A. Chauhan, Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs, Biomaterials 30 (5) (2009) 867–878. http://dx.doi.org/10.1016/j.biomaterials.2008.10.032.
[90] A. Danion, H. Brochu, Y. Martin, P. Vermette, Fabrication and characterization of con- tact lenses bearing surface-immobilized layers of intact liposomes, J. Biomed. Mater. Res. A 82 (1) (2007) 41–51. http://dx.doi.org/10.1002/jbm.a.31147.
[91] A. Danion, I. Arsenault, P. Vermette, Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin, J. Pharm. Sci. 96 (9) (2007) 2350–2363. http://dx.doi.org/10.1002/jps.20871.
[92] H.J. Jung, A. Chauhan, Ophthalmic drug release by contact lenses, 7(3)2012. 1–3. [93] H.J. Jung, M. Abou-Jaoude, B.E. Carbia, C. Plummer, A. Chauhan, Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone–hydrogel contact lenses, J. Control. Release 165 (1) (2013) 82–89. http://dx.doi.org/10.1016/j.
jconrel.2012.10.010.
[94] J.B. Ciolino, C.F. Stefanescu, A.E. Ross, et al., In vivo performance of a drug-eluting
contact lens to treat glaucoma for a month, Biomaterials 35 (1) (2014) 432–439.
http://dx.doi.org/10.1016/j.biomaterials.2013.09.032.
[95] T. Loftsson, M. Másson, M.E. Brewster, Self-association of cyclodextrins and cyclo-
dextrin complexes, J. Pharm. Sci. 93 (5) (2004) 1091–1099. http://dx.doi.org/
10.1002/jps.20047.
[96] J.-F.R. Dos Santos, R. Couceiro, A. Concheiro, J.-J. Torres-Labandeira, C. Alvarez-
Lorenzo, Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/re- lease properties, Acta Biomater. 4 (3) (2008) 745–755. http://dx.doi.org/10.1016/j. actbio.2007.12.008.
[97] J. Xu, X. Li, F. Sun, Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release, Acta Biomater. 6 (2) (2010) 486–493. http://dx. doi.org/10.1016/j.actbio.2009.07.021.
[98] R.X. Kang, The intraocular pressure depressive effect of puerarin, Zhonghua Yan Ke Za Zhi 29 (6) (1993) 336–339 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 7912669. Accessed June 18, 2014).
[99] M.J. García-Fernández, N. Tabary, B. Martel, et al., Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses, Carbohydr. Polym. 98 (2) (2013) 1343–1352. http://dx.doi.org/10.1016/j.carbpol.2013.08.003.
